MedPath

OSPREY PHARMACEUTICALS USA, INC.

OSPREY PHARMACEUTICALS USA, INC. logo
πŸ‡ΊπŸ‡ΈUnited States
Ownership
Private, Subsidiary
Established
1998-01-01
Employees
11
Market Cap
-
Website
http://www.ospreypharma.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)β€’ Click on a phase to view related trials

Phase 1
1 (100.0%)

Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy

Phase 1
Terminated
Conditions
IGA Nephropathy
Proteinuria
First Posted Date
2009-03-06
Last Posted Date
2010-06-02
Lead Sponsor
Osprey Pharmaceuticals USA, Inc.
Target Recruit Count
30
Registration Number
NCT00856674
Locations
πŸ‡¨πŸ‡¦

Eastern Health, HSC, Memorial University, St. John's, Newfoundland and Labrador, Canada

πŸ‡¨πŸ‡¦

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

πŸ‡¨πŸ‡¦

Hoptial Maisonneuve-Rosemont, Montreal, Quebec, Canada

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.